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The translocon of the inner envelope membrane of
chloroplasts (Tic) mediates the late events in the trans-
location of nucleus-encoded preproteins into chloro-
plasts. Tic110 is a major integral membrane component
of active Tic complexes and has been proposed to func-
tion as a docking site for translocation-associated stro-
mal factors and as a component of the protein-conduct-
ing channel. To investigate the various proposed
functions of Tic110, we have investigated the structure,
topology, and activities of a 97.5-kDa fragment of Arabi-
dopsis Tic110 (atTic110) lacking only the amino-termi-
nal transmembrane segments. The protein was ex-
pressed both in Escherichia coli and Arabidopsis as a
stable, soluble protein with a high -helical content.
Binding studies demonstrate that a region of the at-
Tic110-soluble domain selectively associates with chlo-
roplast preproteins at the late stages of membrane
translocation. These data support the hypothesis that
the bulk of Tic110 extends into the chloroplast stroma
and suggest that the domain forms a docking site for
preproteins as they emerge from the Tic translocon.
Chloroplast biogenesis is dependent upon the import of
3000 different nucleus-encoded proteins (1). The majority of
these proteins are synthesized as preproteins carrying an ami-
no-terminal transit peptide that serves as the essential signal
for targeting to the organelle. The transit peptide is recognized
by receptor components of the translocon at the outer envelope
membrane of chloroplasts (Toc), and a GTP-regulated switch
initiates translocation through the protein-conducting channel
of the Toc complex. At this stage, the Toc complex associates
with the translocon at the inner envelope membrane (Tic), and
this Toc-Tic supercomplex mediates the direct transport of the
preproteins from the cytoplasm into the chloroplast stroma (2).
Although many mechanistic details remain to be defined, the
activities of the Toc components have been extensively inves-
tigated. Two membrane-associated GTPases, Toc159 and
Toc34/33, mediate transit peptide recognition and regulate the
initiation of translocation (3–7). The Toc GTPases form a com-
plex with Toc75, an integral membrane protein that, along with
Toc159, constitutes a major component of the protein-conduct-
ing channel (1, 8–10).
In contrast to the Toc complex, the activities and functions of
the Tic components are less well defined. The biochemical
analysis of Tic function has been complicated by the fact that
assembly of functional Tic complexes is dynamic and occurs in
response to preprotein translocation (11). Therefore, the isola-
tion of a stable Tic complex has thus far been elusive. Tic110
was the first Tic component identified and represents a major
component of active Tic complexes (12, 13). It is an integral
inner envelope membrane protein, and structural predictions
suggest that it consists of two predicted transmembrane helices
at its extreme amino terminus and a 97.5-kDa carboxyl-termi-
nal region that is largely hydrophilic. Tic110 transiently asso-
ciates with at least five other Tic proteins. These include Tic20,
a polytopic membrane protein that is implicated in protein
translocation at the inner membrane by covalent cross-linking
and genetic studies (11, 14); Tic22, a peripheral inner mem-
brane protein that may regulate interactions between the Toc
and Tic translocons by sensing preprotein emergence into the
intermembrane space (11, 15); Tic40, an inner membrane pro-
tein that appears to interact with preproteins at late stage in
inner membrane translocation (16); and Tic55 and Tic62, two
inner membrane redox components that are proposed to serve
as regulators of the translocation reaction (17, 18).
Studies of Tic110 topology and molecular interactions have
led to three models for its roles in protein import. In the first
model, the carboxyl-terminal region of pea Tic110, psTic110,
was predicted to extend into the intermembrane space between
the outer and inner envelope membranes and thereby mediate
the interactions between the Toc and Tic complexes during the
translocation reaction (13, 19). However, this model was dis-
counted by detailed topology mapping studies (20). The results
indicated that psTic110 exists in the opposite orientation with
the bulk of the protein extending into the stroma and limited
exposure to the intermembrane space. In the second model, the
large hydrophilic domain of Tic110 is proposed to serve as a
docking site for soluble stromal chaperones that assist in the
translocation and folding of imported proteins (12, 20). In this
scenario, Tic110 would function in a manner analogous to
Tim44, a protein that mediates mtHsp70 localization to the
matrix face of the Tim23 translocon in mitochondria (21). This
model is supported by the topology studies and by the obser-
vation that native psTic110 associates reversibly with the
Hsp93 and Cpn60 chaperones of the chloroplast stroma (12,
22). Recently, this model has been challenged by a third hy-
pothesis. This study proposed that Tic110 is a -barrel mem-
brane protein and functions as the protein-conducting channel
of the Tic translocon (23). These conclusions were based on the
observation that a urea-denatured fragment of psTic110 gave
rise to ion channels when inserted into proteoliposomes. How-
ever, the relevance of the reconstitution data are unclear be-
cause native psTic110 does not form similar channels in recon-
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
stituted proteoliposomes, nor are similar channels observed in
native chloroplast envelope membranes (23).
To examine these three models, we have investigated the
structure, topology, and function ofArabidopsisTic110, atTic110.
We demonstrate that the 97.5-kDa carboxyl-terminal region of
atTic110 lacking only the two predicted transmembrane domains
(atTic11093–996) exists as a soluble protein when expressed in
Escherichia coli and when targeted to chloroplasts in vivo. Cir-
cular dichroism spectra indicate that this region is predomi-
nantly -helical, consistent with secondary structure predictions.
Furthermore, we demonstrate that native Tic110 purified from
pea chloroplasts and recombinant atTic11093–996 bind selectively
to chloroplast preproteins. The transit peptide-binding domain
maps to a site on atTic11093–996 that is predicted to localize close
to the stromal face of the Tic translocon. These data support the
hypothesis that Tic110 acts as a scaffold to coordinate the stro-
mal events of protein translocation into chloroplasts and are
inconsistent with a role for Tic110 as a -barrel channel.
EXPERIMENTAL PROCEDURES
Construction of atTic110 Deletion Mutants and Arabidopsis Trans-
formation—The pre-atTic110 cDNA was amplified from total Arabidop-
sis cDNA by reverse transcription-PCR using primers that introduced
5 XhoI and BspHI sites spanning the start codon and a 3 XbaI site
following the stop codon. The cDNA was inserted into the XhoI and
XbaI sites of pBluescript SK to generate pBS-pre-atTic110 and the
NcoI and XbaI sites of pCAMBIA3300.1 to generate pCAMBIA-pre-
atTic110. The mature atTic110 construct and the deletion construct
atTic11093–966 were generated using PCR with primers that introduced
XhoI and BspHI sites containing start codons immediately upstream
from the amino-terminal codons of the constructs and XbaI sites fol-
lowing the stop codons of the open reading frames. A full-length at-
Tic110 cDNA clone (pBS-pre-atTic110) or an identical clone encoding
the addition of a carboxyl-terminal hexahistidine tag (pBS-atTic110-
His) was used as the template. The PCR products were introduced into
the XhoI and XbaI sites of pBlueScript SK to generate pBS-atTic110
and pBS-atTic11093–966. The pBluescript clones were digested with
BspHI and NotI and subcloned into the NcoI and NotI sites of pET21d
to generate pET21d-atTic110 and pET21d-atTic11093–966. The frag-
ments of atTic110185–966 and atTic110370–966 were generated by PCR
with primers that introduced XhoI sites and BspHI sites containing
start codons immediately upstream from the amino-terminal codons of
the constructs and NotI site following the stop codons of the open
reading frames. The PCR products were directly digested with BspHI
and NotI and subcloned into the NcoI and NotI sites of pET21d to
generate pET21d-atTic110185–966 and pET21d-atTic110370–966. The
pBS-atTic1101–602 construct encoding atTic1101–602 was generated by
digestion of pBS-atTic110 with EcoRV and PstI, treatment with Pfu
DNA polymerase to generate blunt ends, and self-ligation. The
pBS-atTic1101–602 was then digested with BspHI and NotI and sub-
cloned into the NcoI and NotI sites of pET21d to generate pET21d-
atTic1101–602. The pCAMBIA-pre-atTic11093–966 construct encoding
pre-atTic11093–966 was generated by digesting pCAMBIA-pre-atTic110
with NcoI and XbaI and replacing the atTic110 3 fragment with the
BspHI-XbaI fragment of pBS-atTic11093–966. All of the constructs were
confirmed by DNA sequencing.
The pCAMBIA-pre-atTic11093–966 and pCAMBIA-pre-atTic110 con-
structs were introduced into Arabidopsis thaliana (ecotype Was-
silewskija) via Agrobacterium tumefaciens-mediated transformation by
the floral dip method (14). Transformed plants were selected on BASTA,
and the presence of the transgene was confirmed by PCR of genomic
DNA using transgene-specific primers (data not shown).
In Vitro Translation and Expression in E. coli—All of the 35S-labeled
in vitro translation products were generated in a coupled transcription-
translation system containing reticulocyte lysate according to the man-
ufacturer’s recommendations (Promega) using the pET21d constructs
encoding the atTic110 constructs.
FIG. 1. Schematic diagram of the constructs used in this study. The predicted transmembrane domains are shown with shaded boxes. The
hatched boxes indicate the transit peptide. The numbers refer to the amino acid positions, with 1 indicating the amino-terminal residue of
mature atTic110.
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For bacterial expression, pET21d-atTic11093–966-His, pET21d-at-
Tic110185–966-His, and pET21d-atTic110370–966-His were transformed
into E. coli BL21(DE3). Expression was induced with 0.2 mM isopropyl-
1-thio--D-galactopyranoside overnight at 20 °C. The proteins were pu-
rified from soluble E. coli extracts of under nondenaturing conditions
using nickel-NTA1 resin (Novagen, Inc.). The proteins were stored in 40
mM Tris-HCl, pH 8.0, 1 M NaCl, 250 mM imidazole, and 0.02% NaN3 at
4 °C or 80 °C.
Structural Analysis—CD spectra of proteins were measured in 50
mM sodium phosphate buffer, pH 8.0, at a concentration of 5 M pro-
teins on an AVIV 62DS CD spectrophotometer (Aviv Associates, Inc.,
Lakewood, NJ). The -helical content was estimated from the mean
residue ellipticity at 222 nm according to Ref. 24. The secondary struc-
ture was also predicted by the PSIPRED secondary structure prediction
method (25).
Arabidopsis Chloroplast Isolation and Immunoblotting—Wild type
and transgenic Arabidopsis were grown on soil under 18-h day condi-
tions. Chloroplasts were isolated from 3-week-old seedlings as de-
scribed previously (26) with the omission of bovine serum albumin from
all buffers. Isolated intact chloroplasts were separated into membrane
and soluble fractions by lysis in 0.1 M Na2CO3, pH 11.5, followed by
centrifugation at 200,000  g for 20 min. The pellets (membrane frac-
tion) were directly dissolved in 350 mM Tris base, pH 11.0, 5% sodium
dodecyl sulfate, 10% glycerol, and 80 mM dithiothreitol (SDS-PAGE
sample buffer). The soluble proteins were recovered by precipitation
with trichloroacetic acid and dissolved into SDS-PAGE sample buffer.
Intact chloroplasts were treated with 20 g/ml trypsin as described
previously (11). The reisolated chloroplasts were analyzed by SDS-
PAGE and immunoblotting.
Total protein extracts from Arabidopsis were obtained by directly
homogenizing leaves in SDS-PAGE sample buffer. For fractionation of
total membrane and soluble proteins, Arabidopsis leaves were homog-
enized in 50 mM Hepes-KOH, pH 7.5, 0.45 M sucrose, 2 mM dithiothre-
itol, and 2 mM EDTA. The homogenate was filtered through two layers
of Miracloth and centrifuged at 500  g for 2 min. The supernatant was
diluted to either 2 mM ice-cold EDTA or 0.1 M Na2CO3, pH 11.5, and
separated into membrane and soluble fractions as described above and
analyzed by SDS-PAGE and immunoblotting. All of the samples were
resolved by SDS-PAGE, transferred to nitrocellulose membrane, and
immunoblotted with anti-atTic110, anti-atToc33, and anti-atToc75 se-
rums as described previously (14).
Pea Chloroplast Isolation and Preprotein Cross-linking—Intact chlo-
1 The abbreviations used are: NTA, nitrilotriacetic acid agarose;
Tricine, N-[2-hydroxy-1,1-bis(hydroxymethyl)ethyl]glycine; DHFR, di-
hydrofolate reductase; PIRAC, protein import related anion channel;
CRABP, cellular retinoic acid-binding protein; rubisco, ribulose-
bisphosphate carboxylase/oxygenase; APDP, N-[4-(p-azidosalicylam-
ido)butyl]-3(2-pyridyldithio)propionamide; SSU, small subunit of
rubisco.
FIG. 2. Expression of atTic110 deletion mutants in E. coli and their circular dichroism spectra. A, SDS-PAGE profile of the indicated
recombinant atTic110 deletion mutants purified from soluble E. coli extracts by nickel-NTA chromatography. The molecular sizes of standard
proteins (lane 1) are indicated to the left of the figure. The polypeptides were visualized by staining with Coomassie blue. B–D, circular dichroism
spectra of atTic11093–966 (B), atTic110185–966 (C), and atTic110370–966 (D). Note that the negative bands at 208 and 222 nm are typically observed
in proteins with substantial -helical structure.
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roplasts were isolated from 10–14-day-old pea seedlings (Pisum sati-
vum var. Green Arrow) as previously described (11). The modification of
pFd-protA with [125I]APDP and covalent cross-linking reactions with
intact chloroplasts were performed as previously described (9, 27). The
cross-linked products were analyzed on 7.5–15% SDS-PAGE gradient
gels to resolve proteins in the 60–150-kDa range. Thermolysin treat-
ment of intact chloroplasts was performed as described previously (8)
using 0.2 mg protease/ml for 30 min on ice.
To prepare chloroplast envelope membranes, intact chloroplasts
were lysed under hypertonic conditions and separated into soluble and
membrane fractions by differential centrifugation as described by Keeg-
stra and Yousif (28). The total membrane fraction was separated into
envelope and thylakoid membrane fractions by flotation into linear
sucrose gradients as previously described (8). The envelope fractions
were analyzed by SDS-PAGE. The radioactive signals in dried gels were
captured and quantitated using a PhosphorImager SI (Molecular Dy-
namics, Sunnyvale, CA) with the IPLab Gel Scientific Image Processing
version 1.5c program (Signal Analytics, Vienna, VA).
Immunoaffinity Chromatography and Immunoprecipitation Reac-
tions—Envelope membranes corresponding to a mixed outer/inner
membrane population were used for all immunoaffinity chromatogra-
phy reactions. The envelope membranes were purified by the method
described previously (11). For immunoaffinity chromatography under
native conditions, the membranes (100 g of protein) were solubilized
in 50 mM Tricine-KOH, 2 mM EDTA, and 150 mM NaCl (TES buffer)
with 1% (w/v) Triton X-100 for 10 min on ice. The extract was clarified
by centrifugation at 100,000  g for 30 min to remove insoluble aggre-
gates. The supernatant was diluted in half and incubated in the pres-
ence of 2 mM MgCl2 and 1 mM ATP at 26 °C for 5 min. The sample was
applied sequentially to IgG-Sepharose of anti-psToc34 IgG-Sepharose,
anti-psToc86 IgG-Sepharose, and anti-psToc110 IgG-Sepharose (1 ml of
packed matrix containing 5 mg of bound IgG). The Sepharose was
washed with 10 volumes of TES buffer containing 0.2% (w/v) Triton
X-100 and eluted with 0.2 M glycine, pH 2.2, containing 0.2% (w/v) decyl
maltoside. The elutes and unbound fractions were analyzed by SDS-
PAGE and immunoblotting.
The binding of [35S]pre-SSU and [35S]SSU to immunoadsorbed
psTic110 was performed with anti-psTic110 IgG-Sepharose (0.5 ml of
packed matrix containing 2.5 mg of bound IgG) containing bound
psTic110 from envelope membranes (50 g of protein) that had been
subjected to the sequential immunoprecipitation as given above. The
[35S]pre-SSU and [35S]SSU translation products were diluted 40-fold
with 50 mMHepes-KOH, pH 7.5, 50 mM KOAc, 4 mMMgCl2, 0.1% Triton
X-100 (wash buffer) and incubated with the anti-psTic110 IgG-Sepha-
rose containing bound psTic110 for 30 min at 4 °C. The resin was
washed five times with an excess of wash buffer, and bound protein was
eluted with 0.2 M glycine, pH 2.2, 0.1% Triton X-100. The elutes were
analyzed by SDS-PAGE and phosphorimaging.
Immunoprecipitation of psTic110 from chloroplast envelope mem-
branes under denaturing conditions following covalent cross-linking
was performed by the method of Anderson and Blobel (29). Before
immunoprecipitation, the envelope membranes (100 g of protein) were
reduced with -mercaptoethanol to cleave the cross-linker as described
previously (9).
atTic110 Binding Assays—pFd-protA, Fd-protA, pSSU-DHFR, and
DHFR were expressed in E. coli and purified on nickel-NTA resin as
described previously (27). Purified pFd-protA and Fd-protA (30 pmol
each), or pSSU-DHFR and DHFR (250 pmol each) were diluted in 20
mM Hepes-KOH, pH 7.5, 200 mM NaCl, and 0.1% Triton X-100 (binding
buffer) to give a final concentration of 40 mM imidazole. The samples
were bound to 8 l of packed nickel-NTA resin at room temperature for
30 min under constant mixing. The resin was washed once with 400 l
of binding buffer containing 40 mM imidazole. The resin was incubated
with in vitro translated [35S]atTic110 or the [35S]atTic110 deletion
mutants in binding buffer containing 40 mM imidazole for 1 h at room
temperature under constant mixing. The resin was washed three times
with 400 l of ice-cold binding buffer containing 40 mM imidazole. The
bound proteins were eluted from the resin with SDS-PAGE sample
FIG. 3. Localization of atTic110 and atTic11093–966 proteins in transgenic Arabidopsis. A, immunoblots of total protein extracts from wild
type (WT) plants (lane 1) and transgenic plants expressing pre-atTic110 (lane 2) or pre-atTic11093–966 (lane 3) with antibodies raised against
atTic110. Each lane contains 100 g of total protein extract. B, localization of atTic110 and atTic11093–966 in soluble and membrane fractions of
total extracts from wild type and transgenic plants. Total protein extracts from wild type or atTic11093–966 transgenic plants were separated into
membrane (M) or soluble (S) fractions in the presence or absence of sodium carbonate. The membrane (30 g of total protein) and soluble (100 g
of total protein) extracts were resolved by SDS-PAGE and immunoblotted with anti-atTic110. C, localization of atTic110 and atTic11093–966 in
chloroplasts. Isolated intact chloroplasts (Total, 50 g of total protein) from wild type or atTic11093–966 transgenic plants or their corresponding
membrane (M) and soluble (S) fractions were resolved by SDS-PAGE and immunoblotted with anti-atTic110 serum. D, trypsin sensitivity of
atTic110 and atTic11093–966 in intact chloroplasts. Chloroplasts equivalent to 25 g of chlorophyll were treated with 20 g/ml of trypsin on ice for
30 min. Intact chloroplasts were reisolated, resolved by SDS-PAGE, and probed with anti-atTic110, anti-atToc75, and anti-atToc33. The positions
of atTic110 and the atTic11093–966 deletion mutant are indicated to the right of each figure.
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buffer containing 1 M imidazole and resolved by SDS-PAGE.
For the competition assays, purified pFd-protA (30pmol) was diluted
in 20 mM Tris-HCl, pH 7.5, 150 mM NaCl (TBS buffer), and the samples
were bound to 8 l of packed IgG-Sepharose at room temperature for
1 h. The IgG-Sepharose was washed once with 400 l of TBS buffer. The
IgG-Sepharose was incubated with purified competitor (atTic11093–966,
atTic110185–966, atTic110370–966, or CRABP) for 30 min at room temper-
ature under constant mixing. After preincubation with competitor, in
vitro translated [35S]atTic110 or [35S]atTic1101–602 was added and in-
cubated for 1 h at room temperature under constant mixing. The resin
was washed three times with 400 l of ice-cold TBS buffer. The proteins
were eluted from IgG-Sepharose with incubation in 0.2 M glycine, pH
2.2, for 15 min at room temperature under constant mixing. The eluates
were resolved directly by SDS-PAGE.
All of the samples were analyzed on a Storm 840 PhosphorImager
using ImageQuant 1.2 software (Molecular Dynamics). The quantita-
tive binding data are presented as percentages of maximal binding
observed with each translation product.
RESULTS
Structural and Topological Analyses of Recombinant at-
Tic110—As a first step in our analysis of atTic110 function, we
examined the structural features of the native protein. The
primary structure of atTic110 contains two distinguishing fea-
tures, a short amino-terminal region (residues 1–93) contain-
ing two -helical transmembrane segments and a 97.5-kDa
carboxyl terminus that is largely hydrophilic in nature (Fig. 1).
We generated a series of truncated atTic110 constructs lacking
only the two transmembrane domains (atTic11093–966) or the
transmembrane domains and additional portions of the amino
terminus (atTic110185–966 and atTic110370–966) (Fig. 1). All of
the constructs were successfully expressed and purified as sol-
uble proteins in E. coli (Fig. 2A) with only a minor fraction of
each (10–15%) found in insoluble inclusion bodies (data not
shown). The yields ranged from 5 to 10 mg/liter of E. coli
culture. The purified fractions were stable to freeze-thaw cycles
at concentration up to 5 mg/ml. These data indicate that the
proteins are expressed in their native conformations and es-
tablish that the 97.5-kDa carboxyl-terminal region folds into a
stable, soluble domain.
A variety of secondary structure predictions of both atTic110
and psTic110 suggest that the carboxyl-terminal region con-
tains predominantly -helical content. We examined the sec-
ondary structure of recombinant atTic11093–966 by CD spec-
troscopy. The recombinant protein exhibited two strong
negative bands at 208 and 222 nm that are typically observed
in proteins with substantial -helical content (Fig. 2B). The
protein is predicted to contain at least 60–80% -helices based
on the 222 value of 29,088 (24). The CD spectra of
atTic110185–966 and atTic110370–966 give slightly less negative
222 values, yet both are predicted to contain at least 50%
-helical content (Fig. 2, C and D). These results indicate that
the bulk of native atTic110 consists of -helical structure.
To further examine whether atTic11093–966 was soluble or
membrane-integrated, we generated transgenic Arabidopsis
expressing either pre-atTic110, the authentic precursor to at-
Tic110, or pre-atTic11093–966, a construct corresponding to
atTic11093–966 fused to the atTic110 transit peptide (Fig. 1).
The expression of both proteins was confirmed by immunoblot-
ting of total tissue extracts using anti-atTic110 antibodies. The
results from representative transformants for each construct
are shown in Fig. 3A. As predicted, the pre-atTic110 transfor-
mant expressed elevated levels of atTic110 compared with wild
type (Fig. 3A, compare lanes 1 and 2), whereas the pre-
atTic11093–966 transformant contained an additional 99.6-kDa
band not observed in wild type plants (Fig. 3A, lane 3, arrow).
The 99.6-kDa polypeptide corresponds to the hexahistidine-
tagged atTic11093–966 after processing to remove the transit
peptide by the stromal processing peptidase.
Separation of the soluble and membrane fractions by lysis in
buffer at neutral or alkaline pH demonstrated that authentic
atTic110 was exclusively membrane-associated (Fig. 3B,
compare lanes 1 and 2 and lanes 3 and 4). In contrast,
atTic11093–966 was observed exclusively in the soluble fraction
under either lysis condition (Fig. 3B, lanes 6 and 8, arrow). To
confirm that pre-atTic11093–966 was targeted to chloroplasts,
we isolated chloroplasts from wild type and atTic11093–966
transgenic plants. The relative proportion of authentic at-
Tic110 and atTic11093–966 was similar to those observed in the
total plant extracts (Fig. 3, A and C), indicating that pre-
atTic11093–966 was imported into chloroplasts. Separation of
chloroplasts into soluble and membrane fractions indicated
that atTic110 was almost exclusively found in the mem-
brane fraction (Fig. 3C, compare lanes 2 and 3). However,
atTic11093–966 appeared only in the soluble fraction (Fig. 3C,
compare lanes 5 and 6), indicating that the protein localized
to the chloroplast stroma. The stromal localization of
atTic11093–966 was further confirmed by trypsin treatment of
isolated intact chloroplasts. Trypsin is capable of permeating
the outer membrane but not the inner membrane of intact
chloroplasts (11, 12, 20). Both authentic atTic110 and
atTic11093–966 were resistant to trypsin treatment, whereas
the outer membrane components, atToc75 and atToc33, were
digested (Fig. 3D, compare lanes 1 and 2), indicating that
atTic11093–966 localized in the stroma. These data confirm that
atTic11093–966 folds into a soluble domain and support the
conclusion that the predicted transmembrane domains anchor
authentic atTic110 to the membrane.
FIG. 4. Cross-linking of envelope-bound pFd-protA-[125I]APDP
to psTic110. A, energy-depleted pea chloroplasts were incubated with
200 nM urea denatured pFd-protA-[125I]APDP in a standard import
assay in the absence () or presence () of 0.1 mM ATP and GTP, and
cross-linking was induced by photoactivation with UV irradiation. The
total chloroplast envelope fraction was isolated and subjected to SDS-
PAGE and phosphorimaging analysis. The positions of known Toc and
Tic components are indicted at the right of the figure. The asterisk
indicates the position of a 110-kDa cross-linked polypeptide. B, the
envelope membrane fraction from pFd-protA-[125I]APDP cross-linked
chloroplasts (lane 2, A) was dissolved under denaturing conditions and
immunoprecipitated with anti-psTic110 (lane 1) or preimmune serum
(PI, lane 2). The positions of psTic110 and pFd-protA are shown to the
right of the figure.
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Purified atTic110 Binds to Chloroplast Preproteins—Upon
establishing that atTic11093–966 exists as a soluble stromal
domain, we wished to examine the hypothesis that it coordi-
nates the late events in preprotein translocation in the stroma.
A psTic110-chaperone complex is proposed to bind preproteins
as they emerge from the protein-conducting channel of the Tic
complex (12). However, it has not been determined whether
Tic110 forms the initial trans-docking site at the translocon by
binding directly to preproteins or participates indirectly by
bringing chaperones to the site of translocation. To address this
question, we first investigated the ability of native psTic110 to
interact with preproteins using covalent cross-linking and pre-
protein binding approaches. We have previously used a label
transfer cross-linking approach to map the interactions of pre-
proteins with the import machinery during the course of pro-
tein import (27). However, these experiments could not resolve
proteins in the higher molecular weight range, including
Tic110. Therefore, we analyzed cross-linked products on a 7.5–
15% gradient gel to resolve psTic110 from the Toc components.
Isolated pea chloroplasts were incubated with pFd-protA-
[125I]APDP, a chimeric chloroplast preprotein consisting of
preferredoxin fused to staphylococcal protein A, that had
been modified with a label-transfer cross-linking reagent
([125I]APDP) (27). pFd-protA-[125I]APDP was bound in the ab-
sence or presence of ATP and GTP, and cross-linking to nearby
proteins was induced by UV light. Reduction of the cross-
linking reaction results in the transfer of the 125I label to the
cross-linked target and release of the bound preprotein. Previ-
ous studies have shown that the pFd-protA-[125I]APDP fusion
protein binds exclusively to the Toc complex in the absence of
energy (27). The results in Fig. 4A are consistent with the
previous observations. Two Toc components, Toc159 and Toc75,
are the major cross-linked products (Fig. 4A, lane 1). In the
presence of energy, the preprotein forms an import intermedi-
ate that spans both the Toc and Tic translocons. Under these
conditions, Toc75 and two Tic components, Tic22 and Tic20, are
cross-linked to the preprotein as previously observed (Fig. 4A,
lane 2). In addition, a 110-kDa cross-linked polypeptide was
apparent (Fig. 4A, lane 2, asterisk). Immunoprecipitation of the
detergent-solubilized cross-linking reaction with anti-psTic110
serum demonstrated that the cross-linked product was
psTic110 (Fig. 4B, lane 1). These data suggest that Tic110 and
preprotein are in close proximity during translocation at the
Tic translocon.
To further investigate the possibility of a direct interaction
between Tic110 and preprotein, we purified psTic110 from the
envelope of pea chloroplasts and asked whether it could bind
preproteins. A chloroplast envelope fraction enriched in inner
membrane vesicles was dissolved with detergent under native
conditions. The soluble extract was incubated with ATP to
disrupt interactions between Tic110 and its two associated
chaperones, Hsp93 and Cpn60 (12, 20). The fraction then was
subjected to sequential immunadsorbtions with two Toc anti-
sera, anti-psToc34 and anti-psToc159, to deplete any Toc-Tic
supercomplexes that could contaminate the psTic110 fraction.
Finally, psTic110 was adsorbed from the depleted membrane
sample using anti-psTic110 bound to Sepharose. Analysis of
this fraction demonstrated that immunoadsorbed psTic110 was
free of associated chaperones, Toc components, and other
known Tic components (Fig. 5A). The immunoadsorbed
psTic110 was incubated with the precursor ([35S]pre-SSU) or
mature ([35S]SSU) forms of the small subunit of rubisco to test
its ability to specifically bind a chloroplast preprotein. As
shown in Fig. 5B, [35S]pre-SSU was specifically coimmunopre-
cipitated with psTic110, whereas [35S]SSU exhibited no detect-
able binding. The association was not sensitive to ATP, provid-
ing additional evidence that the observed binding was not due
to the presence of residual chaperones (Fig. 5B, compare lanes
2 and 3). Furthermore, the antibodies from the preimmune
serum did not bind [35S]pre-SSU (Fig. 5B, lane 5). In conjunc-
FIG. 5.Direct binding of preprotein to chloroplast-derived psTic110. A, a total chloroplast envelope membrane fraction (100 g of protein)
was dissolved in TES buffer containing 1% Triton X-100 and subjected to sequential immunoaffinity chromatography on anti-psToc34-Sepharose
(-psToc34), anti-psToc159-Sepharose (-psToc159), and anti-psTic110-Sepharose (-psTic110). The eluates from each chromatography step were
analyzed by SDS-PAGE and immunoblotting with the antisera specific for the proteins indicated at the left of the figure. B, in vitro translated (IVT)
[35S]pre-SSU or [35S]SSU was incubated in the presence or absence of ATP with psTic110 bound to anti-psTic110-Sepharose (lane 4, A) or
preimmune IgG-Sepharose. Bound translation products were analyzed by SDS-PAGE and phosphorimaging analysis. The positions of [35S]pre-
SSU and [35S]SSU are shown to the left of the figure. Lanes 1 and 4 contain 10% of the in vitro translation products added to the binding reactions.
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tion with the covalent cross-linking studies, our data indicate
that native Tic110 from chloroplasts directly binds to prepro-
teins via their intrinsic transit peptides.
Direct Interaction between atTic110 and Preproteins—The
observation that Tic110 from pea chloroplasts associates with a
chloroplast preprotein led us to investigate the requirements
and specificity of binding using the recombinant atTic110 con-
structs. To this end, we developed a preprotein binding assay
using immobilized preprotein fusions and in vitro translated
[35S]atTic110. Hexahistidine-tagged preprotein fusions, pFd-
protA and pSSU-DHFR, and their corresponding mature forms
lacking transit peptides, Fd-protA and DHFR, were immobi-
lized on a nickel-NTA resin and incubated with [35S]atTic110.
As shown in Fig. 6A, [35S]atTic110 bound to pFd-protA at
greater than 10-fold higher levels compared with Fd-protA. The
level of binding to Fd-protA was similar to the background
binding observed with nickel-NTA resin alone (Fig. 6B).
[35S]atTic110 binding to pSSU-DHFR was 3-fold higher than
that observed with DHFR (Fig. 6A). DHFR consistently exhib-
ited higher nonspecific binding to all constructs tested (data
not shown). The efficiency of binding to both pFd-protA and
pSSU-DHFR was 15–20% of added [35S]atTic110 (Fig. 6A).
Negligible binding was observed to the nickel-NTA resin alone
(Fig. 6A). These data confirm the ability of atTic110 to bind
preproteins and demonstrate that binding is conferred by the
preprotein transit peptide.
The Preprotein-binding Site of atTic110 Is Localized to the
Soluble Carboxyl-terminal Region—As a next step in our anal-
ysis, we wished to examine the binding specificity and define
the transit peptide binding region of atTic110. For this pur-
pose, we tested the ability of the recombinant atTic110 deletion
constructs (Fig. 1) to compete with [35S]atTic110 for binding to
pFd-protA. For these assays, pFd-protA lacking a hexahisti-
dine tag was immobilized on IgG-Sepharose and incubated
with [35S]atTic110 in the absence or presence of the competitor.
Both atTic11093–966 and atTic110185–966 efficiently inhibit the
binding of [35S]atTic110 to pFd-protA (Fig. 7A). The inhibition
by both proteins is dose-dependent with maximum inhibition
observed between 200 and 500 nM competitor (Fig. 7B). In
contrast, atTic110370–966 does not efficiently inhibit the bind-
ing of [35S]atTic110 to pFd-protA (Fig. 7), suggesting that this
deletion construct lacks the transit peptide-binding site. An
unrelated protein, CRABP, has no effect on [35S]atTic110 bind-
ing at the highest concentration tested (Fig. 7). These data
demonstrate that the interaction between [35S]atTic110 and
the preprotein is specific and suggest that at least part of the
transit peptide-binding domain is located within the amino-
terminal region of atTic110.
To confirm direct binding of atTic110185–966 to prepro-
teins, we tested its ability to bind immobilized pFd-protA and
pSSU-DHFR. Fig. 8 shows that in vitro translated
[35S]atTic110185–966 binds pFd-protA and pSSU-DHFR (Fig. 8)
with a selectivity nearly identical to that observed with full-
length atTic110. It should be noted that the binding efficiency
FIG. 6. Binding of atTic110 to chlo-
roplast preproteins. A, recombinant
pFd-protA, Fd-protA, pSSU-DHFR, or
DHFR were immobilized on nickel-NTA
resin and incubated with in vitro trans-
lated [35S]atTic110. Bound [35S]atTic110
was eluted and analyzed directly by SDS-
PAGE and phosphorimaging analysis.
Lanes 1 and 5 contain 20% of the in vitro
translated [35S]atTic110 added to each
binding reaction. B, quantitative analysis
of data from triplicate experiments in-
cluding those shown in A with bars indi-
cating the standard error.
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of [35S]atTic110185–966 to pFd-protA and pSSU-DHFR is 20%
of that observed with full-length atTic110 (Fig. 6), suggesting
that [35S]atTic110185–966 contains a minimal transit peptide-
binding site. [35S]atTic110370–966 does not bind to pFd-protA or
pSSU-DHFR (Fig. 8A), consistent with its inability to compete
with the binding of full-length atTic110 (Fig. 7). On the basis of
the results in Figs. 7 and 8, we conclude that residues 185–370
form at least part of a binding site for preprotein transit pep-
tides on atTic110.
The role of residues 185–370 in transit peptide binding was
explored further by testing the ability of a carboxyl-terminal
deletion construct of atTic110, atTic1101–602 (Fig. 1), to bind
preproteins. As shown in Fig. 9 (A and B), [35S]atTic1101–602
binds to pFd-protA and pSSU-DHFR. This construct exhibited
similar binding affinities and specificities as we observed with
[35S]atTic110 (Fig. 6A). The binding of [35S]atTic1101–602 to
pFd-protA was inhibited effectively in a dose-dependent man-
ner by recombinant atTic110185–966 (Fig. 9, C and D) at con-
centrations comparable with those that competed binding of
[35S]atTic110 (Fig. 7). atTic110370–966 was not an effective com-
petitor at the concentrations tested (Fig. 9D). Our results in-
dicate that the region between Met185 and Met370 encompasses
a preprotein-binding domain on atTic110. In total, these data
indicate that the carboxyl-terminal, stromal domain of Tic110
forms a trans-binding site for the transit peptide of preproteins
during translocation through the Tic translocon at the inner
envelope membrane.
DISCUSSION
In this paper, we have focused on the role of Tic110 as a
component of the protein translocon at the inner envelope of
chloroplasts. Our goal was to examine the hypotheses that
Tic110 functions primarily as a docking site for stromal import
factors (12, 20), an inner membrane-anchored protein of the
intermembrane space that mediates Toc and Tic translocon
interactions (13, 19), or a -barrel membrane channel for the
Tic translocon (23). Our analyses demonstrate that the carbox-
yl-terminal 97.5 kDa of atTic110 folds into a soluble domain
when expressed both in E. coli (Fig. 2) and in Arabidopsis (Fig.
3), supporting the conclusion that this region forms a hydro-
philic stromal domain. Structural studies confirm that the re-
gion consists predominantly of -helical structure (Fig. 2). Fur-
thermore, we provide both in organello and in vitro evidence
that Tic110 binds directly to preproteins (Figs. 4–6) and dem-
onstrate that a segment of the carboxyl-terminal domain me-
diates this association (Fig. 8). In total, our results support the
hypothesis that the bulk of Tic110 forms a stromal docking site
for factors involved in the late stages of protein import (12, 20)
and extend the activities of the protein to include transit pep-
tide binding at the stromal face of the Tic translocon.
psTic110 originally was isolated as a component of an import
intermediate associated complex containing a bound prepro-
tein (3, 12, 13) and psTic110 antibodies coimmunoprecipitated
preproteins bound to the Tic complex (12, 22). Furthermore,
preproteins appear to bind specifically to inverted inner enve-
lope vesicles (23), consistent with our proposal that the transit
peptide-binding site of Tic110 lies at the inner face of the inner
membrane. However, these previous studies did not distin-
guish between the direct binding of preproteins to Tic110 and
an indirect interaction mediated by the binding of preproteins
to Tic110-associated molecular chaperones or other import
components. Our data demonstrate that atTic110 possesses a
transit peptide-specific binding site for preproteins.
Although the exact conformation of Tic110 remains to be
established, the localization of the transit peptide-binding site
between Met185 and Met370 on atTic110 (Figs. 7–9) suggests
that the site lies adjacent to the exit site of the Tic translocon.
Interestingly, secondary structure prediction suggests that the
transit peptide-binding region is rich in -helices, containing at
least two amphipathic helices with acidic faces between resi-
dues 180–200 and 280–300. Although more detailed structure/
function analysis is required, it is intriguing to speculate that
these regions could interact with transit peptides, all of which
tend to have overall basic characteristics.
The transit peptide binding data and previous reports estab-
lishing the direct association of psTic110 with stromal chaper-
ones led us to propose a model in which Tic110 coordinates the
coupling of translocation and chaperone binding at the stromal
face of the chloroplast inner membrane. On the basis of this
observation, we hypothesize that Tic110 provides a transit
peptide-docking site for preproteins as they emerge from the
protein-conducting channel of the Tic translocon. This docking
could prevent reverse translocation of the imported preprotein,
thereby conferring unidirectional transport into the stroma.
The docking of the chloroplast Hsp93 homologue (chloroplast
ClpC) at Tic110 (22, 30) would concentrate this chaperone at
FIG. 7. Localization of the preprotein binding site of atTic110
to the soluble carboxyl-terminal region. A, in vitro translated (IVT)
[35S]atTic110 was incubated with pFd-protA immobilized on IgG-
Sepharose in the absence or presence of 0.5 M atTic11093–966,
atTic110185–966, atTic110370–966, or CRABP. Bound [
35S]atTic110 was
eluted and analyzed directly by SDS-PAGE and phosphorimaging anal-
ysis. Lane 1 contains 10% of the in vitro translated [35S]atTic110 added
to each binding reaction. B, quantitative analysis of [35S]atTic110 bind-
ing to pFd-protA in the presence of increasing concentrations of the
competitors used in A. Each point represents the mean of triplicate
experiments with bars indicating the standard error.
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the exit site of the translocon and facilitate its binding to the
trapped preprotein. Binding of Hsp93 presumably prevents
misfolding/aggregation and provides the driving force for com-
plete translocation into the stroma (22). The association of the
chloroplast GroEL homologue, Cpn60, with Tic110 (12) would
facilitate folding of the newly imported protein before it dif-
fuses from the site of translocation. In this regard, Tic110
would function in a manner analogous to Tim44 of the mito-
chondrial Tim17/23 translocon and Sec63 of the translocon of
the endoplasmic reticulum, both of which coordinate the bind-
ing of chaperones to translocating polypeptides (31).
Cleavage of the transit peptide is known to occur very early
in the translocation reaction (32). Processing by the stromal
processing peptidase would result in release of the preprotein
from Tic110, allowing translocation to proceed. It is interesting
to speculate that stromal processing peptidase might also tran-
siently interact with the Tic110 to catalyze transit peptide
hydrolysis and dissociation. As such, Tic110 would serve as a
molecular scaffold that coordinates the translocation, process-
ing, and folding of preproteins at the Tic translocon. The as-
sembly of the stromal factors mediating these events would
generate a protected environment for the maturation of newly
imported preproteins similar to that envisioned in the lumen of
the endoplasmic reticulum (31). Future studies will reveal the
degree to which Tic110 plays an active or passive role in the
coordination of these events.
The expression and CD data presented here are in contrast
with the proposal that Tic110 forms a protein-conducting chan-
nel with stable -barrel structure. The results from the previ-
ous study (23) were based on the use of a reconstituted system
consisting of a urea-denatured carboxyl-terminal fragment of
psTic110 that was incorporated into liposomes. This fragment
corresponded to residues 178–958 of psTic110, a construct very
similar to the atTic110185–966 deletion mutant used in this
study. The analysis of the secondary structure content of the
detergent-stabilized protein prior to insertion into liposomes
indicated a lack of -helices consistent with high -strand
content (23). Our results using native atTic110370–966,
atTic110185–966, and atTic11093–966 indicate a high -helical
content consistent with secondary structure predictions. It is
unlikely that the difference in the results can be attributed to
differences in the primary structures of the Arabidopsis and
pea proteins, because the carboxyl-terminal regions exhibit
70% sequence identity throughout their primary structures
(data not shown).
Previous targeting and topology studies also support the
conclusion that Tic110 consists largely of a hydrophilic stromal
domain with short transmembrane anchors at its extreme
amino terminus. Topology mapping assays in intact chloro-
plasts (12, 20) and isolated inner envelope membrane vesicles
(20, 23) have shown that the protease sensitivity of the carbox-
yl-terminal region of psTic110 is identical to authentic stromal
FIG. 8. Direct binding of atTic-
110185–966 and atTic110370–966 to chlo-
roplast preproteins. A, in vitro trans-
lated (IVT) [35S]atTic110185–966 or
[35S]atTic110370–966 was incubated with
immobilized pFd-protA, Fd-protA, pSSU-
DHFR, or DHFR as described under “Ex-
perimental Procedures.” Bound [35S]at-
Tic110185–966 or [
35S]atTic110370–966 was
eluted and analyzed directly by SDS-
PAGE and phosphorimaging analysis.
Lanes 1 and 5 contain 20% of the in vitro
translated [35S]atTic110185–966 or
[35S]atTic110370–966 added to each bind-
ing reaction. B, quantitative analysis of
data from [35S]atTic110185–966 binding
(upper panel of A) with bars indicating the
standard error of triplicate experiments.
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proteins that associate peripherally with the inner face of the
inner membrane (20) and is distinct from proteins of the outer
envelope and intermembrane space (12, 20, 23). Our results
also support these observations (Fig. 3D). These data indicate
that the carboxyl terminus is not exposed at the outer surface
of the inner membrane as would be expected if the domain
formed multiple membrane spans. The topology studies also
discount another proposal that this domain extends into the
intermembrane space and interacts with the Toc machinery
(13). Targeting studies using fusion proteins containing the
amino-terminal region of psTic110 demonstrated that this re-
gion was necessary and sufficient for targeting and anchoring
authentic psTic110 to the inner membrane (19), supporting
this region as the Tic110 membrane anchor.
A channel with characteristics similar to that measured
using the reconstituted psTic110 fragment is not observed in
chloroplasts or isolated inner envelope membranes (23), rais-
ing questions about the physiological relevance of the recon-
stitution data. Furthermore, reconstitution of native
psTic110 into proteoliposomes does not yield a channel sim-
ilar to that observed with the denatured fragment (23). A
protein import related anion channel (PIRAC) has previously
been identified in intact chloroplasts (33, 34) with conduct-
ance characteristics distinct from the reconstituted psTic110
fragment. PIRAC activity was efficiently inhibited by authen-
tic preferredoxin but not import incompetent deletion mu-
tants (35), indicating that PIRAC was specifically linked to
protein import. Similar selective activity was not demon-
strated for the reconstituted psTic110 fragment (23). Inter-
estingly, antibodies to psTic110 inhibited the PIRAC chan-
nel, consistent with the observation that Tic110 is closely
associated with the inner membrane translocation channel.
In fact, we do not exclude the possibility that the amino-
terminal transmembrane region of Tic110 participates di-
rectly in translocation by forming a part of the Tic protein-
conducting channel. Furthermore, we cannot rule out the
possibility entirely that the carboxyl-terminal domain might
undergo a reversible conformational change in response to
preprotein translocation that results in the insertion of this
region into the inner membrane in a -barrel structure. Such
dramatic conformational shifts have been observed for a spe-
cialized group of bacterial toxins (36). However, there is no
evidence to support such a switch in Tic110 conformation,
and the structural and topology studies make it highly un-
likely that the carboxyl-terminal region forms a -barrel.
Tic110 associates dynamically with Tic20 (11), an integral
inner membrane Tic component, with similarity to the
Tim17/23 channel components of a mitochondrial inner mem-
brane protein translocon (11). We have provided genetic and
biochemical evidence that Tic20 participates in inner mem-
brane translocation (14). Therefore, it is possible that Tic110
and Tic20 assemble with other Tic proteins in response to
translocation across the outer membrane to form the Tic chan-
nel and provide a trans-binding site to initiate preprotein
translocation across the inner membrane.
FIG. 9. Direct binding of atTic1101–602 to chloroplast preproteins. A, in vitro translated (IVT) [
35S]atTic1101–602 was incubated with
immobilized pFd-protA, Fd-protA, pSSU-DHFR, or DHFR as described in the legend to Fig. 6. Bound [35S]atTic1101–602 was eluted and analyzed
directly by SDS-PAGE and phosphorimaging analysis. Lane 1 contains 20% of the in vitro translated [35S]atTic1101–602 added to each binding
reaction. B, quantitative analysis of data from triplicate experiments including those shown in Awith bars indicating the standard error. C, in vitro
translated [35S]atTic1101–602 was incubated with IgG-Sepharose-immobilized pFd-protA in the absence or presence of increasing concentrations of
atTic110185–966, atTic110370–966, or CRABP. Bound [
35S]atTic1101–602 was eluted and analyzed directly by SDS-PAGE and phosphorimaging
analysis. Lane 1 contains 10% of the in vitro translated [35S]atTic110 added to each binding reaction. D, quantitative analysis of data from
triplicate experiments including those shown in C with bars indicating the standard error.
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